Dr Ellie Shingler is the Strategic Feasibility Manager at Boehringer Ingelheim UK & Ireland. Ellie leads the country and site-level clinical trial strategic feasibility assessment process within the UK and Ireland. In her role, she drives early engagement with external experts, centres of excellence, and patient organisations to enhance trial feasibility, start-up, and recruitment activities.
Ellie brings extensive experience from both the pharmaceutical industry and trial site operations, offering a unique perspective on optimising trial delivery. She is passionate about improving access to clinical trials through close collaboration with health systems and research infrastructure.
Ellie holds a BSc in Public Health, a Master of Research in Health, and a PhD completed within a biomedical research centre, providing a strong foundation in population health and translational research.
